Authors:
Wirtz, PW
Roep, BO
Schreuder, GMT
van Doorn, PA
van Engelen, BGM
Kuks, JB
Twijnstra, A
de Visser, M
Visser, LH
Wokke, JH
Wintzen, AR
Verschuuren, JJ
Citation: Pw. Wirtz et al., HLA class I and II in Lambert-Eaton myasthenic syndrome without associatedtumor, HUMAN IMMUN, 62(8), 2001, pp. 809-813
Authors:
van Koningsveld, R
Rico, R
Gerstenbluth, I
Schmitz, PIM
Ang, CW
Merkies, ISJ
Jacobs, BC
Halabi, Y
Endtz, HP
van der Meche, FGA
van Doorn, PA
Citation: R. Van Koningsveld et al., Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean islandCuracao, NEUROLOGY, 56(11), 2001, pp. 1467-1472
Authors:
Koga, M
Ang, CW
Yuki, N
Jacobs, BC
Herbrink, P
van der Meche, FGA
Hirata, K
van Doorn, PA
Citation: M. Koga et al., Comparative study of preceding Campylobacter jejuni infection in Guillain-Barre syndrome in Japan and The Netherlands, J NE NE PSY, 70(5), 2001, pp. 693-695
Authors:
Ang, CW
de Klerk, MA
Endtz, HP
Jacobs, BC
Laman, JD
van der Meche, FGA
van Doorn, PA
Citation: Cw. Ang et al., Guillain-Barre syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM(1) and anti-GQ(1b) antibodies in rabbits, INFEC IMMUN, 69(4), 2001, pp. 2462-2469
Authors:
Yuki, N
Ang, CW
Koga, M
Jacobs, BC
van Doorn, PA
Hirata, K
van der Meche, FGA
Citation: N. Yuki et al., Clinical features and response to treatment in Guillain-Barre syndrome associated with antibodies to GM1b ganglioside, ANN NEUROL, 47(3), 2000, pp. 314-321
Authors:
Ang, CW
van Doorn, PA
Endtz, HP
Merkies, ISJ
Jacobs, BC
de Klerk, MA
van Koningsveld, R
van der Meche, FGA
Citation: Cw. Ang et al., A case of Guillain-Barre syndrome following a family outbreak of Campylobacter jejuni enteritis, J NEUROIMM, 111(1-2), 2000, pp. 229-233
Authors:
De Letter, MACJ
van Doorn, PA
Savelkoul, HFJ
Laman, JD
Schmitz, PIM
Op de Coul, AAW
Visser, LH
Kros, JM
Teepen, JLJM
van der Meche, FGA
Citation: Macj. De Letter et al., Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue, J NEUROIMM, 106(1-2), 2000, pp. 206-213
Authors:
Ang, CW
Endtz, HP
Jacobs, BC
Laman, JD
de Klerk, MA
van der Meche, FGA
van Doorn, PA
Citation: Cw. Ang et al., Campylobacter jejuni lipopolysaccharides from Guillain-Barre syndrome patients induce IgG anti-GM1 antibodies in rabbits, J NEUROIMM, 104(2), 2000, pp. 133-138
Citation: Pa. Van Doorn et Fga. Van Der Meche, IVIg treatment improves multifocal motor neuropathy - Easy to start but difficult to stop, NEUROLOGY, 55(9), 2000, pp. 1246-1247
Authors:
van der Pol, WL
van den Berg, LH
Scheepers, RHM
van der Bom, JG
van Doorn, PA
van Koningsveld, R
van den Broek, MCL
Wokke, JHJ
van de Winkel, JGJ
Citation: Wl. Van Der Pol et al., IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome, NEUROLOGY, 54(8), 2000, pp. 1661-1665
Authors:
Ang, CW
Jacobs, BC
Brandenburg, AH
Laman, JD
van der Meche, FGA
Osterhaus, ADME
van Doorn, PA
Citation: Cw. Ang et al., Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome, NEUROLOGY, 54(7), 2000, pp. 1453-1458
Authors:
Merkies, ISJ
Schmitz, PIM
van der Meche, FGA
van Doorn, PA
Citation: Isj. Merkies et al., Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies, J NE NE PSY, 68(5), 2000, pp. 669-671
Authors:
Megens-de Letter, MACJ
Visser, LH
van Doorn, PA
Savelkoul, HFJ
Citation: Macj. Megens-de Letter et al., Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy, EUR CYTOKIN, 10(4), 1999, pp. 471-477
Authors:
Visser, LH
Schmitz, PIM
Meulstee, J
van Doorn, PA
van der Meche, FGA
Citation: Lh. Visser et al., Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange, NEUROLOGY, 53(3), 1999, pp. 598-604
Authors:
Martina, ISJ
van Doorn, PA
Schmitz, PIM
Meulstee, J
van der Meche, FGA
Citation: Isj. Martina et al., Chronic motor neuropathies: response to interferon-beta 1a after failure of conventional therapies, J NE NE PSY, 66(2), 1999, pp. 197-201